Alnylam Pharmaceuticals (NasdaqGS:ALNY) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsChristine Lindenboom - Chief Corporate Communications OfficerJeff Poulton - CFOPushkal Garg - Chief Research and Development OfficerTolga Tanguler - Chief Commercial OfficerYvonne Greenstreet - CEOConference Call ParticipantsEllie Merle - AnalystJames Sheehan - AnalystKostas Theodoslou - AnalystLuca Issi - AnalystMike Ulz - AnalystMyles Minter - AnalystPaul Chiaramonte - AnalystRitu Baral - Analys ...